A comprehensive analysis of the correlation between plasma cytokines/chemokines and tumor immune microenvironment signature influences the response of checkpoint inhibitors in advanced non‐small‐cell lung cancer

Documenti analoghi

• Rechallenge of immune checkpoint inhibitors in advanced non‐small cell lung cancer
  di: Gen Lin, et al.
  Pubblicazione: (2024)
• Counting Graphlets of Size $k$ under Local Differential Privacy
  di: Suppakitpaisarn, Vorapong, et al.
  Pubblicazione: (2025)
• Sex‐specific cytokine, chemokine, and growth factor signatures in T1D patients and progressors
  di: Khyati Girdhar, et al.
  Pubblicazione: (2024)
• Predictive capacity of immune‐related adverse events and cytokine profiling in neoadjuvant immune checkpoint inhibitor trials for head and neck squamous cell carcinoma
  di: Angela E. Alnemri, et al.
  Pubblicazione: (2024)
• The impact of Foxp3 + regulatory T‐cells on CD8 + T‐cell dysfunction in tumour microenvironments and responses to immune checkpoint inhibitors
  di: Mikhaël Attias, et al.
  Pubblicazione: (2024)